van Es-Johansson An — SEC insider filings
SEC reporting owner CIK 1795902. 20 insider filings on record with FilingPulse; latest filed 2026-10-01.
Transaction summary — filings shown
Covers all 20 filings on record, filed 2020-12-17 to 2026-10-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CERENOME, INC. (CNSY) | Director | 9 | — | — | 12 |
| LUMOS PHARMA, INC. (LUMO) | Director | 5 | — | — | 11 |
| Savara Inc (SVRA) | Director | 6 | — | — | 6 |
Insider filings — van Es-Johansson An
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-01 | 4 | CERENOME, INC. (CNSY) | Option exercise (M): 921 @ $0 · Option exercise (M): 921 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Option exercise (M): 922 @ $0 · Option exercise (M): 922 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 3,686 (derivative) @ $0 · Grant/award (A): 3,686 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-08-15 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 297,794 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 40,122 (derivative) @ $0 | EDGAR |
| 2024-12-16 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2024-12-13 | 4 | LUMOS PHARMA, INC. (LUMO) | Disposition to issuer (D): 1,100 · Disposition to issuer (D): 3,345 (derivative) · Disposition to issuer (D): 3,328 (derivative) · Disposition to issuer (D): 3,431 (derivative) · Disposition to issuer (D): 2,910 (derivative) · Disposition to issuer (D): 5,729 (derivative) | EDGAR |
| 2024-09-12 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 3,650 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | LUMOS PHARMA, INC. (LUMO) | Grant/award (A): 3,328 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 2,250 (derivative) @ $0 | EDGAR |
| 2023-12-15 | 4 | Savara Inc (SVRA) | Grant/award (A): 22,500 @ $0 | EDGAR |
| 2023-05-12 | 4 | LUMOS PHARMA, INC. (LUMO) | Grant/award (A): 3,345 (derivative) @ $0 | EDGAR |
| 2023-02-17 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 20,182 (derivative) @ $0 | EDGAR |
| 2022-12-15 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | LUMOS PHARMA, INC. (LUMO) | Grant/award (A): 3,431 (derivative) @ $0 | EDGAR |
| 2021-12-14 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2021-05-27 | 4 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/award (A): 6,336 (derivative) @ $0 | EDGAR |
| 2021-05-24 | 4 | LUMOS PHARMA, INC. (LUMO) | Grant/award (A): 367 @ $0 · Grant/award (A): 2,910 (derivative) @ $0 | EDGAR |
| 2020-12-17 | 4 | Savara Inc (SVRA) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1795902 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs